NEW YORK, New York – 29th July 2026 – Immigration Evaluation announced expanded intake and appointment coverage for immigration-related psychological evaluations in Houston, Texas, and Louisiana, ...
An FDA advisory committee will hold meetings this week to review applications for novel therapies disfavored by those who ...
A regional evaluation found gaps in shared decision making for inherited bleeding disorders despite strong patient confidence ...
The food allergy market landscape is advancing through a robust clinical pipeline, with key programs being developed by companies such as DBV Technologies (Viaskin [DBV712] Peanut Patch), Novartis ...
Introduction Mental health conditions are prevalent during adolescence, but access to early evidence-based treatments remains ...
Neuro Energizer launches 7-second audio program citing Einstein brain research as binaural beat research expands in ...
Top doctors answer common questions about mammography—from when to start screening and whether it's safe to understanding ...
Forte Biosciences is being acquired by Argenx for $2.2 billion [$77/share], capping near-term upside. Click here to read my ...
Jaguar remains sharply focused on its ongoing global development program for oral crofelemer as adjunctive therapy to ...
Danon disease has been misclassified as cone dystrophy, cone-rod dystrophy, or retinitis pigmentosa; distinguishing features include the absence of optic disc pallor, bone-spicule pigmentation, and a ...
(Nasdaq: GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending the marketing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results